Flexion Therapeutics (NASDAQ:FLXN), Cara Therapeutics (NASDAQ:CARA), and Nektar Therapeutics (NASDAQ:NKTR) may soon offer patients suffering from chronic pain a better option than opioids. Here’s how these companies plan to reshape the way doctors treat the 39 million Americans with chronic pain.
